May 21, 2015
The use of a vaccine as an adjunct to existing control measures in the face of devastating mortality from H5N2 highly pathogenic avian influenza implies a consideration of available vaccines. CEVA Vectormune HVT-AIV is reviewed for the benefit of subscribers to EGG-CITE the key facts are summarized:-
Characteristics of the CEVA Vectormune HVT-AIV Vaccine
Subscribers are referred to the EGG-CITE Editorial on May 15th which reviewed the benefits and negative considerations relating to a change in APHIS policy to allow vaccination.
* Kapczynski, D. et al Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2avian influenza. Vaccine. 33:1197-1205 (2015)